Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Budd-Chiari Syndrome
This book offers a systematic introduction to Budd-Chiari syndrome, a rare but life-threatening vascular disorder of the liver, which refers to obstructions at any site from the hepatic veins to the suprahepatic inferior vena cava. The book mainly covers the history, epidemiology, etiology and risk factors, pathology, diagnosis, pharmacological and interventional aspects, surgical treatment, etiological treatment, and prognostic assessment of Budd-Chiari syndrome. Notably, it also presents cutting-edge research findings in this field. The early diagnosis of Budd-Chiari syndrome is vital, as it allows clinicians to pursue more targeted and effective treatment strategies, thus improving patient outcomes. However, much information, including the latest advances, has not yet been fully disseminated in current clinical practice. This book addresses that gap, helping physicians to improve diagnosis and establish standard treatment strategies, helping researchers conduct clinical and experimental studies, and even helping patients and their relatives to recognize this disease.
Anticoagulation
This book consists of two major sections, except for the introductory chapter by two editors regarding anticoagulation for portal vein thrombosis in liver cirrhosis. The first section includes four chapters, which provide an overview of knowledge regarding the history, indications, and laboratory monitoring of anticoagulation and electrochemical anticoagulant methods. The second section also includes four chapters, which aim to summarize the current evidence regarding anticoagulation in various clinical scenarios, including COVID-19, peripheral artery diseases, iliofemoral deep vein thrombosis, and ambulatory cancer patients. These chapters are useful for guiding how to use anticoagulants in routine clinical practice, manage patients with thrombotic diseases by anticoagulants, and design future studies regarding anticoagulation.
Variceal Bleeding in Liver Cirrhosis
This book discusses the management of variceal bleeding in liver cirrhosis, covering a wide range of topics, including epidemiology, mechanism, diagnosis and monitoring, prophylaxis, treatment, and prognostic assessment. It also presents the latest research in the field, such as non-invasive approaches, self-expanding metal stents, hemostatic powder, and early TIPS. The book is a valuable resource for physicians wanting to establish standard treatment strategies, researchers launching innovative clinical and experimental studies, and also for patients and their relatives wishing to gain a better understanding of this disease.
Digestive System
The book focuses on the recent advances in the digestive system. It is composed of 3 sections: gastrointestinal duct, liver, and biliary system. There are 9 chapters: peptic ulcers; mid-gastrointestinal bleeding; gastrointestinal manifestations of IgA vasculitis; biomechanics of intestinal contractions; evaluation of serum sodium change after terlipressin in cirrhosis; history and background of biliary system; gallbladder carcinoma; ERCP for cholecysto-choledocholithiasis; and cystic artery variations and associated vascular complications in laparoscopic cholecystectomy. The knowledge presented in this book should be valuable for family physicians, internists, gastroenterologists, hepatologists, endoscopists, radiologists, and pathologists who are interested in digestive diseases to guide the clinical practice and management. This book should be also useful for patients and their relatives to better understand the digestive system.
Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management
Liver cirrhosis, the final stage of various chronic liver diseases, poses significant health challenges and carries a severe prognosis. This book provides a comprehensive review of the advancements in the diagnosis and management of liver cirrhosis and its complications. Spanning six chapters, this book delves into critical areas including diagnostic approaches and therapeutic strategies for cirrhosis, transarterial radioembolization (TARE) for hepatocellular carcinoma, the pathology of hepatic encephalopathy, and clinical applications of non-selective beta blockers (NSBBs) in cirrhosis management. Bringing together clinical and pathological perspectives, this book features contributions from esteemed authors worldwide. This multidisciplinary approach ensures a thorough understanding of the progress in diagnosing and managing cirrhosis and its complications. This book is designed to offer healthcare professionals, researchers, and students fresh insights and innovative approaches, aiming to enhance diagnostic and therapeutic practices for liver cirrhosis.
Management of Chronic Liver Diseases
This book is contributed by worldwide experts in the field of liver diseases. It comprises of 3 sections and 6 chapters to introduce the intra-abdominal hypertension and abdominal compartment syndrome in chronic liver diseases, ascites with hyponatremia, acute kidney injury, portal vein thrombosis, spontaneous bacterial peritonitis in liver cirrhosis, and the use of stereotactic body radiation therapy in hepatocellular carcinoma. Clinicians and investigators who are interested in the management of chronic liver diseases will be acquainted with its merits and usefulness.
Portal Hypertension
Portal Hypertension - Recent Advances discusses several important topics related to portal hypertension, such as pediatric portal hypertension, sinusoidal obstructions syndrome, endoscopy in the management of portal hypertension, and non-invasive assessment of esophageal varices, along with recent advances in the field.
Advances in Hepatology
This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. This transformative nature of DAA therapy underpins the goal of the World Health Organization (WHO) to eliminate HCV infection as a public health threat by 2030. The advantages of using these therapies include high efficacy (sustained virological response rate >95%) with minimal side effects, good tolerability, easy drug administration (once-daily oral dosing) and short duration of treatment (8-12 weeks). The commercialization of second-generation DAA agents due to their high effectiveness, few side-effects and pangenotypic action. This transformative nature of DAA therapy underpins the goal of the WHO to eliminate HCV infection as a public health threat by 2030.
Hepatitis C - Recent Advances
This book provides a comprehensive overview of hepatitis C infection. It includes two sections. The first section includes four chapters that discuss the structure, diagnostic methods, phylogenetic classification, and multiscale viral dynamics modeling of the hepatitis C virus and its interaction with host genetics. The second section includes four chapters that summarize the existing strategy of hepatitis C virus elimination, management of hepatitis C virus in patients with chronic kidney disease, and association of hepatitis C virus with hepatic and extrahepatic malignancy. This book is a useful resource for investigators studying hepatitis C infection and physicians treating the disease.
Liver Cirrhosis
Liver cirrhosis represents one of the major challenges for most physicians and surgeons on a global scale. This book provides practicing hepatologists, gastroenterologists and liver surgeons with a valuable tool in their efforts to understand the (molecular) mechanisms involved, be updated regarding the newest and less invasive diagnostic methods, and educate themselves about the challenges involved in the management of liver cirrhosis and its complications. The authors of this book represent a team of true global experts on the topic. In addition to the knowledge shared, the authors provide their personal clinical experience on a variety of different aspects of liver cirrhosis, giving us a well-rounded overview.
